Concentrate for preparation of solution for infusions of 5 mg/ml, on 2 ml in ampoules from dark glass (5 ampoules in blister strip packagings, on 1-2 packagings complete with an ampoule knife in a cardboard pack);
Solution for injections of 5 mg/ml, on 2 ml in ampoules from dark glass (5 ampoules in blister strip packagings, on 1 or 2 packagings complete with an ampoule knife in a cardboard pack);
Tablets of 5 mg, ploskotsilindrichesky, with a facet, color white or white with a yellowish shade, (10 pieces in blister strip packagings, 2 or 5 packagings in a cardboard pack; 30 pieces in blister strip packagings, 1 or 3 packagings in a cardboard pack).

Active agent of drug – a Vinpocetine.

Indications to use

Chronic and acute insufficiency of cerebral circulation;
The Distsirkulyatorny encephalopathy which is followed by a headache, dizziness, memory disturbances;
Vascular diseases of a choroid of an eye and retina;
Posttraumatic encephalopathy;
Vegeto-vascular dystonia at a menopausal syndrome;
Menyer's disease, deterioration in hearing of toxic or vascular genesis, dizziness of a labyrinth origin.

Contraindications

Pregnancy;
Hypersensitivity to drug components.

For parenteral use of the Vinpocetine in addition contraindications are:

Severe forms of arrhythmia;
Heavy coronary heart disease.

The drug uses by the feeding women given about safety are absent.

Route of administration and dosage

Inside the Vinpocetine is accepted by 3 times a day on 5-10 mg. An initial daily dose – 15 mg, maximum – 30 mg.

Drug in the form of injections most often is used at acute states in a single dose 20 mg. At good tolerance within 3-4 days the dose is raised to 1 mg/kg.

Therapy duration – 10-14 days. In the course of cancellation the dosage of drug should be reduced gradually. In a year no more than 2-3 courses of administration of drug are allowed.

Side effects

Cardiovascular system and blood (hemostasis, hemopoiesis): delay of intra ventricular conductivity; a depression of a segment of ST and lengthening of an interval of QT, tachycardia, hypotension, premature ventricular contraction, erubescence, thrombophlebitis in an injection site;
Nervous system and sense bodys: headache, dizziness, weakness, drowsiness, sleeplessness;
Bodies of the digestive tract (DT): heartburn, nausea, dryness in a mouth;
Integuments: perspiration;
Other: allergic reactions.

Special instructions

The Vinpocetine inside should be taken with caution at stenocardia, arrhythmia, the lowered vascular tone and unstable arterial pressure.

As a rule, parenterally drug is used in acute cases, and, after improvement of a clinical picture, passed to reception in the form of tablets.

At treatment of chronic diseases drug should be accepted inside.

Parenteral administration at a hemorrhagic cerebral stroke is allowed only after reduction of the acute phenomena (as a rule, 5-7 days later).

Medicinal interaction

At simultaneous use of the Vinpocetine with warfarin there were messages on small decrease in anticoagulating action of the last.

At combined parenteral use with heparin increase in risk of developing of bleedings is possible.

Terms and storage conditions

To store in protected from light, the place, dry, unavailable to children.

Period of validity:

Concentrate for preparation of solution for infusions – 2 years at a temperature up to 25 °C;
Solution for injections – 2 years at a temperature of 10-30 °C;
Tablets – 3 years at a temperature of 15-25 °C.

The prices in Internet drugstores:

Name of drug

Price

Drugstore

Vinpocetine of a tablet 5 of Mg of 50 pieces

60 rub.

To buy